Mallia Aesthetics has developed MAL-838, a hormone-free product derived from sCD83, which stimulates hair growth without disrupting the skin microbiome. sCD83 promotes hair growth by activating hair follicles and preventing cell death, offering a localized treatment without systemic side effects.
HairClone is developing cell replacementtreatments to rejuvenate and generate hair follicles, and has launched a crowdfunding campaign. A user expressed skepticism aboutthe need for crowdfunding.
PP405 shows promise for reactivating hair follicles, with potential maintenance using 5AR inhibitors. Currenttreatments like Minoxidil and finasteride are effective but have limitations, and there is hope for more effective solutions in the future.
HairClone aims to rejuvenate miniaturizing hair follicles through follicle banking and cell expansion, with treatments potentially available in the UK by 2022. The process involves extracting, storing, and cloning hair follicles, but full regenerative treatments will take many years to develop.